Related Experiment Video
Updated: Jun 24, 2026

07:20
Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
cis-Dichloridobis{dimethyl[3-(9-phosphabicyclo[3.3.1]non-9-yl)propyl]amine-kappaP}platinum(II)
1Sasol Technology Research and Development, 1 Klasie Havenga Road, Sasolburg 1947, South Africa.
Summary
This study details a sterically bulky phosphine ligand in a platinum complex, revealing its rare cis geometry and unique crystal packing. The research quantifies the ligand
Area of Science:
- Coordination Chemistry
- Organometallic Chemistry
- Crystallography
Background:
- Square-planar platinum complexes are crucial in catalysis and medicine.
- Sterically demanding ligands often favor trans geometries.
- Understanding ligand effects on complex geometry is key.
Purpose of the Study:
- To characterize the crystal structure of a platinum complex with a bulky phosphine ligand.
- To investigate the geometric preferences of sterically hindered ligands in square-planar environments.
- To determine the effective cone angle of the novel phosphine ligand.
Main Methods:
- Single-crystal X-ray diffraction analysis.
- Structural elucidation of the platinum complex.
- Calculation of the ligand's effective cone angle.
Main Results:
- The title compound, [PtCl2(ligand)2], crystallizes in a cis geometry, a rare occurrence for bulky ligands.
- The phosphine ligand, dimethyl[3-(9-phosphabicyclo[3.3.1]non-9-yl)propyl]amine (Phoban[3.3.1]-C3NMe2), exhibits random packing disorder.
- The effective cone angle was calculated to be between 160-181 degrees.
Conclusions:
- Sterically bulky ligands can adopt cis geometries in square-planar platinum complexes.
- The Phoban[3.3.1]-C3NMe2 ligand possesses significant steric bulk.
- Crystal packing and intermolecular interactions influence the overall structure.

![Mizoroki-Heck Cross-coupling Reactions Catalyzed by Dichloro{bis[1,1',1''-(phosphinetriyl)tripiperidine]}palladium Under Mild Reaction Conditions](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F51444.jpg&w=3840&q=50)